scispace - formally typeset
A

Ann B. Vernallis

Researcher at Aston University

Publications -  20
Citations -  1048

Ann B. Vernallis is an academic researcher from Aston University. The author has contributed to research in topics: Glycoprotein 130 & Leukemia inhibitory factor. The author has an hindex of 11, co-authored 20 publications receiving 904 citations.

Papers
More filters
Journal ArticleDOI

Bromelain's activity and potential as an anti-cancer agent: Current evidence and perspectives.

TL;DR: It is suggested that the anti-cancer activity of bromelain consists in the direct impact on cancer cells and their micro-environment, as well as in the modulation of immune, inflammatory and haemostatic systems.
Journal ArticleDOI

Leukemia inhibitory factor and its receptor promote adipocyte differentiation via the mitogen-activated protein kinase cascade.

TL;DR: The results are in favor of a model that implicates stimulation of LIF receptor in the commitment of preadipocytes to undergo terminal differentiation by controlling the early expression of C/EBPβ and C-EBPδ genes via the mitogen-activated protein kinase cascade.
Journal ArticleDOI

Nrf2 activation supports cell survival during hypoxia and hypoxia/reoxygenation in cardiomyoblasts; the roles of reactive oxygen and nitrogen species

TL;DR: The hypothesis that Nrf2 activation by reactive oxygen and nitrogen species modulates cytotoxicity during hypoxia (H) with and without reoxygenation (H/R) in H9C2 cardiomyoblasts is explored and distinctive roles for ROS and RNS during H and H/R for NRF2 induction are supported which are important for survival independently of GSH salvage.
Journal ArticleDOI

Proteomic analysis of the anti‐inflammatory action of minocycline

TL;DR: The observation that minocycline inhibits some, but not all, of the LPS‐induced proteomic changes shows that minocrycline specifically affects some signalling pathways and does not completely inhibit macrophage activation.